The United States Endoscope-Radiofrequency Ablation (RFA) market holds the largest share within North America, driven by increasing incidences of Barrett’s esophagus, gastrointestinal cancers, and chronic digestive disorders requiring advanced therapeutic intervention. The country benefits from widespread adoption of technologically advanced endoscopic systems, a strong network...